Our CEO/CSO, Dr. Satoshi Tamaki, will be presenting at the Antibody Engineering & Therapeutics Asia 2024, an international conference held in Kyoto from October 21 to 23, 2024. On October 22 at 14:30, he will deliver a talk titled “Integration of AI and Wet Lab for the Design of Novel Antibodies” as part of the “AI-Enabled and Computationally-Guided Antibody Discovery & Engineering” stream.

In this presentation, Tamaki will showcase case studies where our AI-driven antibody design technology successfully generated antibodies with high binding affinity as well as antibodies targeting diverse epitopes. He will also propose our generative AI methods for designing antibodies with desired functionalities through minimal experimental validation.

We welcome attendees to join his talk and learn more about our cutting-edge AI technologies.